Abstract
Pharmacological intervention of redox balance in cancer cells often results in oxidative stress-mediated apoptosis, attracting much attention for the development of a new generation of targeted therapy in cancer. However, little is known about mechanisms underlying the conversion from oxidative signaling to downstream activities leading cells to death.
| Original language | English |
|---|---|
| Pages (from-to) | e7538 |
| Journal | PLOS ONE |
| Volume | 4 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Proteasome Inhibitors
- Apoptosis
- Antineoplastic Agents
- Endoplasmic Reticulum
- HL-60 Cells
- DNA-Binding Proteins
- Humans
- Protease Inhibitors
- Gene Expression Regulation, Neoplastic
- Oxidation-Reduction
- Oxygen
- Neoplasms
- Transcription Factors
- Oxidative Stress
- Fenretinide
- Signal Transduction
- U937 Cells
- NF-E2-Related Factor 2
Fingerprint
Dive into the research topics of 'Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver